Association of Reproductive Health Professionals
Association of Reproductive Health Professionals
Reproductive Health Topics Publications & Resources Professional Education Newsroom Membership Policy & Advocacy About Us
CME/CE Opportunities - By FORMAT
Send To A Friend Send To A Friend Bookmark this Page Share this page
Webinars

Diagnosis and Pharmacological Treatment of Overactive Bladder




On Demand Sessions:

Expiration Date Presenter Are you seeking credit?
April 27, 2019 Stephen R. Kraus MD, FACS Review webinar for CME/CE credit*

Review webinar without credit

*By clicking the webinar with credit link, you confirm that you have read the accreditation information on this page.

This is a one-hour internet-based activity. To receive continuing education credit, learners should 1) take the pre-test 2) review the webinar and 3) complete the post-test.

Learning Objectives

  • Identify the early symptoms of OAB and discuss when to treat and when to refer to a specialist
  • Describe the impact of OAB on other co-morbidities and quality of life
  • List the signs of OAB and formulate an appropriate differential diagnosis in order to provide evidence-based care
  • Review pharmacological treatment options for patients with OAB
  • Explain to patients the importance of treatment

Accreditation Information

Continuing Medical Education Credits: ARHP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. ARHP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education Credits: ARHP is approved by the California Board of Registered Nursing, Provider Number 16643, to provide nursing continuing education credits. This activity is approved for 1.0 contact hours.

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This program was made possible through independent educational grants from Astellas.

Disclosures:

  • Tomas L. Griebling, MD, MPH, (planning committee), has nothing to disclose.
  • Stephen R. Kraus MD, FACS, (faculty), is a consultant and speaker for Astellas and a consultant and teaching faculty for Allergan and Medtronic.
  • Sima Michaels Dembo, (medical writer), has nothing to disclose.
  • Anne Moore, DNP, WHNP, FAANP, (planning committee), has nothing to disclose.
  • Mary H. Palmer PhD, RNC, FAAN, AGSF, (planning committee), has nothing to disclose.
  • Doris Quintanilla (program manager) has nothing to disclose.

Back